Sio Capital Management, LLC
Filing Date
Global Rank
#2,105
/ 8,420
▲ 776
Top Industry
Biotechnology
39.5%
3Y Alpha vs SPY
-2.4%
Period ended 6 months ago
Filed Feb 17, 2026 · 4mo
24 quarters · since Mar 2020
Clone Performance
Jun 2023–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+66.1%
SPY
+76.3%
Annualised alpha
-2.4%
Max drawdown
−37.3%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
65 positions · as of Dec 31, 2025 · Δ vs Sep 30, 2025Top Position
7.2%
−5.3 pts
Top 5
33.4%
−5.7 pts
Top 10
51.9%
−6.5 pts
HHI
371
Diversified−128
Portfolio Trend
24 quarters · across all stocks
Sector Breakdown
As of Dec 31, 2025| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 89.1% | $586,555,244 |
| Industrials | 6.6% | $43,186,241 |
| Consumer Defensive | 3.8% | $25,278,874 |
| Unclassified | 0.5% | $3,259,985 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
8 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| KVUE | Kenvue Inc. | +621,442 | 1,465,442 | $25,278,874 | |
| SNY | Sanofi | +408,983 | 971,686 | $47,087,903 | |
| AVR | Anteris Technologies Global Corp. | +102,040 | 1,874,641 | $9,354,458 | |
| PRQR | ProQR Therapeutics N.V. | +89,042 | 2,164,181 | $4,371,645 | |
| TFX | Teleflex Inc | +46,819 | 86,876 | $10,602,347 | |
| ANIP | Ani Pharmaceuticals Inc | +31,549 | 87,272 | $6,889,251 | |
| TYRA | Tyra Biosciences, Inc. | +11,055 | 526,002 | $13,828,592 | |
| BMRN | Biomarin Pharmaceutical Inc | +7,574 | 232,688 | $13,828,647 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
15 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| NMTC | NEUROONE MEDICAL TECHNOLOGIES Corp | −1,220,595 | 1,140,040 | $864,150 | |
| ALKS | Alkermes plc. | −579,487 | 95,353 | $2,667,976 | |
| AQST | Aquestive Therapeutics, Inc. | −505,000 | 993,095 | $6,415,393 | |
| CELC | Celcuity Inc. | −309,459 | 477,067 | $47,582,662 | |
| IRON | Disc Medicine, Inc. | −227,201 | 57,586 | $4,572,904 | |
| SI | Shoulder Innovations, Inc. | −122,029 | 227,971 | $3,259,985 | |
| CNC | Centene Corp | −113,250 | 274,350 | $11,289,502 | |
| SVRA | Savara Inc | −112,963 | 613,888 | $3,701,744 | |
| DRUG | Bright Minds Biosciences Inc. | −108,881 | 81,883 | $6,390,149 | |
| HAE | Haemonetics Corp | −105,404 | 92,631 | $7,424,374 | |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | −103,247 | 474,503 | $19,554,268 | |
| EWTX | Edgewise Therapeutics, Inc. | −69,700 | 237,481 | $5,893,091 | |
| MMS | Maximus, Inc. | −57,311 | 500,304 | $43,186,241 | |
| CRNX | Crinetics Pharmaceuticals, Inc. | −50,000 | 124,841 | $5,811,348 | |
| IDYA | IDEAYA Biosciences, Inc. | −48,500 | 75,730 | $2,617,986 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
25 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| CI | Cigna Group | 172,203 | $47,395,431 | |
| ZBH | Zimmer Biomet Holdings, Inc. | 385,642 | $34,676,928 | |
| RYTM | Rhythm Pharmaceuticals, Inc. | 265,700 | $28,440,528 | |
| OGN | Organon & Co. | 3,421,765 | $24,534,055 | |
| ICLR | Icon PLC | 127,202 | $23,178,748 | |
| WAY | Waystar Holding Corp. | 613,725 | $20,099,493 | |
| LIVN | LivaNova PLC | 322,382 | $19,836,164 | |
| XLO | Xilio Therapeutics, Inc. | 2,134,537 | $19,125,451 | |
| BHVN | Biohaven Ltd. | 1,244,764 | $14,053,385 | |
| GPCR | Structure Therapeutics Inc. | 201,500 | $14,014,325 | |
| BTSG | BrightSpring Health Services, Inc. | 308,010 | $11,534,974 | |
| CRL | Charles River Laboratories International, Inc. | 54,985 | $10,968,407 | |
| TARA | Protara Therapeutics, Inc. | 1,715,394 | $9,143,050 | |
| CCRN | Cross Country Healthcare Inc | 1,068,821 | $8,657,450 | |
| ABVX | Abivax S.A. | 43,124 | $5,815,487 | |
| COR | Cencora, Inc. | 15,900 | $5,370,225 | |
| MCK | Mckesson Corp | 6,400 | $5,249,856 | |
| FULC | Fulcrum Therapeutics, Inc. | 382,000 | $4,320,420 | |
| ORKA | Oruka Therapeutics, Inc. | 118,126 | $3,580,399 | |
| KYMR | Kymera Therapeutics, Inc. | 32,235 | $2,508,205 | |
| ELTX | Elicio Therapeutics, Inc. | 296,900 | $2,363,324 | |
| HYPR | Hyperfine, Inc. | 2,000,000 | $1,958,000 | |
| OTLK | Outlook Therapeutics, Inc. | 1,125,400 | $1,778,132 | |
| IBIO | iBio, Inc. | 740,000 | $1,428,200 | |
| ADGM | Adagio Medical Holdings, Inc. | 1,288,461 | $1,339,999 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
9 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| MRK | Merck & Co., Inc. | 177,300 | $14,880,789 | |
| HSIC | Henry Schein Inc | 219,207 | $14,548,768 | |
| GSK | GSK plc | 268,873 | $11,604,558 | |
| KALV | KalVista Pharmaceuticals, Inc. | 683,819 | $8,328,915 | |
| NVCR | NovoCure Ltd | 413,829 | $5,346,670 | |
| SLP | Simulations Plus, Inc. | 320,307 | $4,827,026 | |
| SEPN | Septerna, Inc. | 189,199 | $3,558,833 | |
| ERAS | Erasca, Inc. | 1,369,748 | $2,986,050 | |
| APRE | Aprea Therapeutics, Inc. | 112,223 | $165,528 | |
| No positions match the current search. | ||||
65 positions ·
$658,280,344 total
· as of Dec 31, 2025
Showing 1–50
of 65 positions by value
· page 1 of 2
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| CELC |
Celcuity Inc.
Healthcare
|
Reduced | 477,067 | $47,582,662 | 7.23% | |
| CI |
Cigna Group
Healthcare
|
NEW | 172,203 | $47,395,431 | 7.20% | |
| SNY |
Sanofi
Healthcare
|
Added | 971,686 | $47,087,903 | 7.15% | |
| MMS |
Maximus, Inc.
Industrials
|
Reduced | 500,304 | $43,186,241 | 6.56% | |
| ZBH |
Zimmer Biomet Holdings, Inc.
Healthcare
|
NEW | 385,642 | $34,676,928 | 5.27% | |
| RYTM |
Rhythm Pharmaceuticals, Inc.
Healthcare
|
NEW | 265,700 | $28,440,528 | 4.32% | |
| KVUE |
Kenvue Inc.
Consumer Defensive
|
Added | 1,465,442 | $25,278,874 | 3.84% | |
| OGN |
Organon & Co.
Healthcare
|
NEW | 3,421,765 | $24,534,055 | 3.73% | |
| ICLR |
Icon PLC
Healthcare
|
NEW | 127,202 | $23,178,748 | 3.52% | |
| WAY |
Waystar Holding Corp.
Healthcare
|
NEW | 613,725 | $20,099,493 | 3.05% | |
| LIVN |
LivaNova PLC
Healthcare
|
NEW | 322,382 | $19,836,164 | 3.01% | |
| DNTH |
Dianthus Therapeutics, Inc. /DE/
Healthcare
|
Reduced | 474,503 | $19,554,268 | 2.97% | |
| XLO |
Xilio Therapeutics, Inc.
Healthcare
|
NEW | 2,134,537 | $19,125,451 | 2.91% | |
| BHVN |
Biohaven Ltd.
Healthcare
|
NEW | 1,244,764 | $14,053,385 | 2.13% | |
| GPCR |
Structure Therapeutics Inc.
Healthcare
|
NEW | 201,500 | $14,014,325 | 2.13% | |
| BMRN |
Biomarin Pharmaceutical Inc
Healthcare
|
Added | 232,688 | $13,828,647 | 2.10% | |
| TYRA |
Tyra Biosciences, Inc.
Healthcare
|
Added | 526,002 | $13,828,592 | 2.10% | |
| BTSG |
BrightSpring Health Services, Inc.
Healthcare
|
NEW | 308,010 | $11,534,974 | 1.75% | |
| CNC |
Centene Corp
Healthcare
|
Reduced | 274,350 | $11,289,502 | 1.71% | |
| CRL |
Charles River Laboratories International, Inc.
Healthcare
|
NEW | 54,985 | $10,968,407 | 1.67% | |
| TFX |
Teleflex Inc
Healthcare
|
Added | 86,876 | $10,602,347 | 1.61% | |
| AVR |
Anteris Technologies Global Corp.
Healthcare
|
Added | 1,874,641 | $9,354,458 | 1.42% | |
| TARA |
Protara Therapeutics, Inc.
Healthcare
|
NEW | 1,715,394 | $9,143,050 | 1.39% | |
| CCRN |
Cross Country Healthcare Inc
Healthcare
|
NEW | 1,068,821 | $8,657,450 | 1.32% | |
| MODD |
Modular Medical, Inc.
Healthcare
|
Held | 785,824 | $8,581,198 | 1.30% | |
| HAE |
Haemonetics Corp
Healthcare
|
Reduced | 92,631 | $7,424,374 | 1.13% | |
| ANIP |
Ani Pharmaceuticals Inc
Healthcare
|
Added | 87,272 | $6,889,251 | 1.05% | |
| AQST |
Aquestive Therapeutics, Inc.
Healthcare
|
Reduced | 993,095 | $6,415,393 | 0.97% | |
| DRUG |
Bright Minds Biosciences Inc.
Healthcare
|
Reduced | 81,883 | $6,390,149 | 0.97% | |
| EWTX |
Edgewise Therapeutics, Inc.
Healthcare
|
Reduced | 237,481 | $5,893,091 | 0.90% | |
| ABVX |
Abivax S.A.
Healthcare
|
NEW | 43,124 | $5,815,487 | 0.88% | |
| CRNX |
Crinetics Pharmaceuticals, Inc.
Healthcare
|
Reduced | 124,841 | $5,811,348 | 0.88% | |
| RAPP |
Rapport Therapeutics, Inc.
Healthcare
|
Held | 185,265 | $5,620,940 | 0.85% | |
| COR |
Cencora, Inc.
Healthcare
|
NEW | 15,900 | $5,370,225 | 0.82% | |
| MCK |
Mckesson Corp
Healthcare
|
NEW | 6,400 | $5,249,856 | 0.80% | |
| IRON |
Disc Medicine, Inc.
Healthcare
|
Reduced | 57,586 | $4,572,904 | 0.69% | |
| PRQR |
ProQR Therapeutics N.V.
Healthcare
|
Added | 2,164,181 | $4,371,645 | 0.66% | |
| FULC |
Fulcrum Therapeutics, Inc.
Healthcare
|
NEW | 382,000 | $4,320,420 | 0.66% | |
| SVRA |
Savara Inc
Healthcare
|
Reduced | 613,888 | $3,701,744 | 0.56% | |
| ORKA |
Oruka Therapeutics, Inc.
Healthcare
|
NEW | 118,126 | $3,580,399 | 0.54% | |
| PMVP |
PMV Pharmaceuticals, Inc.
Healthcare
|
Reduced | 2,636,548 | $3,295,685 | 0.50% | |
| SI |
Shoulder Innovations, Inc.
|
Reduced | 227,971 | $3,259,985 | 0.50% | |
| ALGS |
Aligos Therapeutics, Inc.
Healthcare
|
Held | 335,937 | $3,130,932 | 0.48% | |
| VIR |
Vir Biotechnology, Inc.
Healthcare
|
Held | 478,343 | $2,884,408 | 0.44% | |
| ALKS |
Alkermes plc.
Healthcare
|
Reduced | 95,353 | $2,667,976 | 0.41% | |
| IDYA |
IDEAYA Biosciences, Inc.
Healthcare
|
Reduced | 75,730 | $2,617,986 | 0.40% | |
| KYMR |
Kymera Therapeutics, Inc.
Healthcare
|
NEW | 32,235 | $2,508,205 | 0.38% | |
| ELTX |
Elicio Therapeutics, Inc.
Healthcare
|
NEW | 296,900 | $2,363,324 | 0.36% | |
| OVID |
Ovid Therapeutics Inc.
Healthcare
|
Held | 1,427,495 | $2,326,816 | 0.35% | |
| CNTX |
Context Therapeutics Inc.
Healthcare
|
Held | 1,341,636 | $1,972,204 | 0.30% |